The prognosis of bulky hepatocellular carcinoma with nonmajor branch portal vein tumor thrombosis

por Jang, Tyng-Yuan, Huang, Ching-I., Yeh, Ming-Lun, Lin, Zu-Yau, Chen, Shinn-Cherng, Chuang, Wan-Long
Publicado 2019

Feasibility and efficacy of helical tomotherapy in cirrhotic patients with unresectable hepatocellular carcinoma

por Huang, Chun-Ming, Huang, Ming-Yii, Tang, Jen-Yang, Chen, Shinn-Cherng, Wang, Liang-Yen, Lin, Zu-Yau, Huang, Chih-Jen
Publicado 2015

The impact of an additional extra-hepatic primary malignancy on the outcomes of patients with hepatocellular carcinoma

por Yeh, Ming-Lun, Huang, Ching-I, Huang, Chung-Feng, Hsieh, Ming-Yen, Lin, Zu-Yau, Huang, Jee-Fu, Dai, Chia-Yen, Yu, Ming-Lung, Chen, Shinn-Cherng, Chuang, Wan-Long
Publicado 2017

Tolloid-like 1 genetic variants determine fibrosis regression in chronic hepatitis C patients with curative antivirals

por Huang, Chung-Feng, Yeh, Ming-Lun, Huang, Ching-I, Lin, Zu-Yau, Chen, Shinn-Cherng, Huang, Jee-Fu, Dai, Chia-Yen, Chuang, Wan-Long, Chen, Jyh-Jou, Yu, Ming-Lung
Publicado 2018

High versus standard doses interferon-alpha in the treatment of naïve chronic hepatitis C patients in Taiwan: a 10-year cohort study

por Yu, Ming-Lung, Dai, Chia-Yen, Chen, Shinn-Cherng, Lee, Li-Po, Hsieh, Ming-Yen, Lin, Zu-Yau, Hsieh, Ming-Yuh, Wang, Liang-Yen, Tsai, Jung-Fa, Chang, Wen-Yu, Chuang, Wan-Long
Publicado 2005

Pegylated-Interferon Alpha Therapy for Treatment-Experienced Chronic Hepatitis B Patients

por Yeh, Ming-Lun, Peng, Cheng-Yuan, Dai, Chia-Yen, Lai, Hsueh-Chou, Huang, Chung-Feng, Hsieh, Ming-Yen, Huang, Jee-Fu, Chen, Shinn-Cherng, Lin, Zu-Yau, Yu, Ming-Lung, Chuang, Wan-Long
Publicado 2015

Association of hyperuricemia with disease severity in chronic hepatitis C patients

por Jang, Tyng-Yuan, Yeh, Ming-Lun, Huang, Ching-I, Lin, Zu-Yau, Chen, Shinn-Cherng, Hsieh, Meng-Hsuan, Dai, Chia-Yen, Huang, Jee-Fu, Huang, Chung-Feng, Chuang, Wan-Long, Yu, Ming-Lung
Publicado 2018

The effect of antiviral therapy on serum lipid profiles in chronic hepatitis C

por Batsaikhan, Batbold, Huang, Ching-I, Yeh, Ming-Lun, Huang, Chung-Feng, Hou, Nei-Jen, Lin, Zu-Yau, Chen, Shinn-Cherng, Huang, Jee-Fu, Yu, Ming-Lung, Chuang, Wan-Long, Lee, Jin-Ching, Dai, Chia-Yen
Publicado 2018

Pretreatment glucose status determines HCC development in HCV patients with mild liver disease after curative antiviral therapy

por Huang, Chung-Feng, Yeh, Ming-Lun, Huang, Cing-Yi, Tsai, Pei-Chien, Ko, Yu-Min, Chen, Kuan-Yu, Lin, Zu-Yau, Chen, Shinn-Cherng, Dai, Chia-Yen, Chuang, Wan-Long, Huang, Jee-Fu, Yu, Ming-Lung
Publicado 2016

Lower protein expression levels of MHC class I chain-related gene A in hepatocellular carcinoma are at high risk of recurrence after surgical resection

por Huang, Chung-Feng, Wang, Shu-Chi, Chang, Wen-Tsan, Yeh, Ming-Lun, Huang, Ching-I, Lin, Zu-Yau, Chen, Shinn-Cherng, Chuang, Wan-Long, Huang, Jee-Fu, Dai, Chia-Yen, Chen, Yao-Li, Yu, Ming-Lung
Publicado 2018

Revisiting the Stopping Rule for Hepatitis C Genotype 1 Patients Treated with Peginterferon Plus Ribavirin

por Yu, Ming-Lung, Liu, Chen-Hua, Huang, Chung-Feng, Tseng, Tai-Chung, Huang, Jee-Fu, Dai, Chia-Yen, Lin, Zu-Yau, Chen, Shinn-Cherng, Wang, Liang-Yen, Juo, Suh-Hang Hank, Chuang, Wan-Long, Kao, Jia-Horng
Publicado 2012

PNPLA3 genetic variants determine hepatic steatosis in non-obese chronic hepatitis C patients

por Huang, Chung-Feng, Chen, Jyh-Jou, Yeh, Ming-Lun, Huang, Ching-I, Hsieh, Ming-Yen, Yang, Hua-Ling, Dai, Chia-Yen, Huang, Jee-Fu, Lin, Zu-Yau, Chen, Shinn-Cherng, Chuang, Wan-Long, Chen, Yao-Li, Yu, Ming-Lung
Publicado 2015

Post-treatment alpha fetoprotein and platelets predict hepatocellular carcinoma development in dual-infected hepatitis B and C patients after eradication of hepatitis C

por Yeh, Ming-Lun, Huang, Ching-I, Huang, Chung-Feng, Hsieh, Meng-Hsuan, Hsieh, Ming-Yen, Lin, Zu-Yau, Chen, Shinn-Cherng, Huang, Jee-Fu, Kuo, Po-Lin, Kuo, Hsing-Tao, Dai, Chia-Yen, Yu, Ming-Lung, Chuang, Wan-Long
Publicado 2018

Equal treatment efficacy of direct-acting antivirals in patients with chronic hepatitis C and hepatocellular carcinoma? A prospective cohort study

por Huang, Chung-Feng, Yeh, Ming-Lun, Huang, Ching-I, Liang, Po-Cheng, Lin, Yi-Hung, Hsieh, Ming-Yen, Wei, Yu-Ju, Lin, Zu-Yau, Chen, Shinn-Cherng, Huang, Jee-Fu, Dai, Chia-Yen, Chuang, Wan-Long, Yu, Ming-Lung
Publicado 2019

Virological Predictors of Response to Retreatment in Hepatitis C Genotype 2 Infected Patients

por Huang, Chung-Feng, Dai, Chia-Yen, Yeh, Ming-Lun, Huang, Jee-Fu, Huang, Ching-I, Hsieh, Ming-Yen, Lin, Zu-Yau, Chen, Shinn-Cherng, Wang, Liang-Yen, Juo, Suh-Hang Hank, Chuang, Wan-Long, Lin, Yi-Ching, Yu, Ming-Lung
Publicado 2013

HATT: a phase IV, single-arm, open-label study of sorafenib in Taiwanese patients with advanced hepatocellular carcinoma

por Lin, Shi-Ming, Lu, Sheng-Nan, Chen, Ping-Tsung, Jeng, Long-Bin, Chen, Shinn-Cherng, Hu, Chi-Tan, Yang, Sien-Sing, Le Berre, Marie-Aude, Liu, Xuan, Mitchell, David Y., Prins, Klaas, Grevel, Joachim, Peña, Carol A. E., Meinhardt, Gerold
Publicado 2016

Role of IL-28B genetic variants in HCV-related liver disease severity in patients with different viral genotypes

por Huang, Ching-I, Huang, Chung-Feng, Yeh, Ming-Lun, Lin, Yi-Hung, Liang, Po-Cheng, Liu, Shang-Yin Vanson, Hsieh, Meng-Hsuan, Lin, Zu-Yau, Chen, Shinn-Cherng, Huang, Jee-Fu, Chuang, Wan-Long, Dai, Chia-Yen, Yu, Ming-Lung
Publicado 2018

Personalized Therapy of Chronic Hepatitis C and B Dually Infected Patients With Pegylated Interferon Plus Ribavirin: A Randomized Study

por Yeh, Ming-Lun, Hsieh, Ming-Yen, Huang, Ching-I., Huang, Chung-Feng, Hsieh, Meng-Hsuan, Liang, Po-Cheng, Lin, Yi-Hung, Hou, Nai-Jen, Lin, Zu-Yau, Chen, Shinn-Cherng, Huang, Jee-Fu, Dai, Chia-Yen, Chuang, Wan-Long, Yu, Ming-Lung
Publicado 2015

Genetics Variants and Serum Levels of MHC Class I Chain-related A in Predicting Hepatocellular Carcinoma Development in Chronic Hepatitis C Patients Post Antiviral Treatment

por Huang, Chung-Feng, Huang, Cing-Yi, Yeh, Ming-Lun, Wang, Shu-Chi, Chen, Kuan-Yu, Ko, Yu-Min, Lin, Ching-Chih, Tsai, Yi-Shan, Tsai, Pei-Chien, Lin, Zu-Yau, Chen, Shinn-Cherng, Dai, Chia-Yen, Huang, Jee-Fu, Chuang, Wan-Long, Yu, Ming-Lung
Publicado 2016

Diversity of the association of serum levels and genetic variants of MHC class I polypeptide-related chain A with liver fibrosis in chronic hepatitis C

por Huang, Chung-Feng, Huang, Ching-I, Yeh, Ming-Lun, Wang, Shu-Chi, Chen, Kuan-Yu, Ko, Yu-Min, Lin, Ching-Chih, Tsai, Yi-Shan, Tsai, Pei-Chien, Lin, Zu-Yau, Chen, Shinn-Cherng, Dai, Chia-Yen, Huang, Jee-Fu, Chuang, Wan-Long, Yu, Ming-Lung
Publicado 2017